Search research articles
Contact Us
Filters
Showing results (21-30 of 69) with videos related to
Page
of 7
Sort By:
Journal of Clinical Pharmacology
|
April 27, 2017
Population Pharmacokinetics of Dexmedetomidine in Infants
Rachel G Greenberg, Huali Wu, Matthew Laughon, et al.
Infection Control and Hospital Epidemiology
|
June 14, 2011
Coagulase-negative staphylococcal infections in the neonatal intensive care unit
Naomi Jean-Baptiste, Daniel K Benjamin, Michael Cohen-Wolkowiez, et al.
The Journal of Pediatrics
|
August 15, 2016
Sedation, Analgesia, and Paralysis during Mechanical Ventilation of Premature Infants
Kanecia O Zimmerman, P Brian Smith, Daniel K Benjamin, et al.
American Journal of Perinatology
|
April 28, 2016
Center Variation in the Delivery of Indicated Late Preterm Births
Sofia Aliaga, Jun Zhang, D Leann Long, et al.
The Journal of Pediatrics
|
February 24, 2024
Measuring Clinical Benefit in Neonatal Randomized Clinical Trials: Challenges and Opportunities
An N Massaro, Beth Boyer, Mira Gill, et al.
Pediatric Research
|
December 15, 2010
Blood protein concentrations in the first two postnatal weeks that predict bronchopulmonary dysplasia among infants born before the 28th week of gestation
Carl Bose, Matthew Laughon, Elizabeth N Allred, et al.
Pediatrics
|
July 22, 2009
Chronic lung disease and developmental delay at 2 years of age in children born before 28 weeks' gestation
Matthew Laughon, Michael T O'Shea, Elizabeth N Allred, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association
|
July 25, 2023
Early antibiotic exposure in very-low birth weight infants and infection risk at 3-7 days after birth
Sarah A Coggins, Zachary Willis, Daniel K Benjamin, et al.
Contemporary Clinical Trials Communications
|
February 20, 2026
Pharmacokinetics, safety and preliminary efficacy study of montelukast in critically ill infants with developing bronchopulmonary dysplasia (PRISM)
Jason E Lang, Daniel Gonzalez, Chi D Hornik, et al.
Pediatrics
|
January 2, 2009
A pilot randomized, controlled trial of later treatment with a peptide-containing, synthetic surfactant for the prevention of bronchopulmonary dysplasia
Matthew Laughon, Carl Bose, Fernando Moya, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 69) with videos related to
Sort By:
Page
of 7
Journal of Clinical Pharmacology
|
April 27, 2017
Population Pharmacokinetics of Dexmedetomidine in Infants
Rachel G Greenberg, Huali Wu, Matthew Laughon, et al.
Infection Control and Hospital Epidemiology
|
June 14, 2011
Coagulase-negative staphylococcal infections in the neonatal intensive care unit
Naomi Jean-Baptiste, Daniel K Benjamin, Michael Cohen-Wolkowiez, et al.
The Journal of Pediatrics
|
August 15, 2016
Sedation, Analgesia, and Paralysis during Mechanical Ventilation of Premature Infants
Kanecia O Zimmerman, P Brian Smith, Daniel K Benjamin, et al.
American Journal of Perinatology
|
April 28, 2016
Center Variation in the Delivery of Indicated Late Preterm Births
Sofia Aliaga, Jun Zhang, D Leann Long, et al.
The Journal of Pediatrics
|
February 24, 2024
Measuring Clinical Benefit in Neonatal Randomized Clinical Trials: Challenges and Opportunities
An N Massaro, Beth Boyer, Mira Gill, et al.
Pediatric Research
|
December 15, 2010
Blood protein concentrations in the first two postnatal weeks that predict bronchopulmonary dysplasia among infants born before the 28th week of gestation
Carl Bose, Matthew Laughon, Elizabeth N Allred, et al.
Pediatrics
|
July 22, 2009
Chronic lung disease and developmental delay at 2 years of age in children born before 28 weeks' gestation
Matthew Laughon, Michael T O'Shea, Elizabeth N Allred, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association
|
July 25, 2023
Early antibiotic exposure in very-low birth weight infants and infection risk at 3-7 days after birth
Sarah A Coggins, Zachary Willis, Daniel K Benjamin, et al.
Contemporary Clinical Trials Communications
|
February 20, 2026
Pharmacokinetics, safety and preliminary efficacy study of montelukast in critically ill infants with developing bronchopulmonary dysplasia (PRISM)
Jason E Lang, Daniel Gonzalez, Chi D Hornik, et al.
Pediatrics
|
January 2, 2009
A pilot randomized, controlled trial of later treatment with a peptide-containing, synthetic surfactant for the prevention of bronchopulmonary dysplasia
Matthew Laughon, Carl Bose, Fernando Moya, et al.
Page
of 7